Spectranano Laboratories Private Limited, a active private limited company, was established on 09 March 2017 in Chennai, Tamil Nadu, India. Engaging in other within the manufacturing sector, it holds CIN: U36999TN2017PTC115401. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Abhishek Sharma (Director), Karthik Veerabadran (Managing Director), Chetan Shankar Sharma (Additional Director). Past directors included Abhishek Sharma, Anil Sharma, Sharada Chaturvedi. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.18A, Old No.27, New No.10, Parameswari Nagar, 2Nd Street, Adyar, Chennai, Tamil Nadu, 600020.
U36999TN2017PTC115401
115401
09 March 2017
₹1.00 M
₹1.00 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Spectranano Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhishek Sharma | Director | 16 Mar 2018 | Current |
| Karthik Veerabadran | Managing Director | 09 Mar 2017 | Current |
| Chetan Shankar Sharma | Additional Director | 07 May 2024 | Current |
| Karthik Vithikaa | Additional Director | 07 May 2024 | Current |
| Uma Rani | Whole-Time Director | 09 Mar 2017 | Current |
| Sharada Chaturvedi | Director | 16 Mar 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
| Pramod Abcsdd | Director | 03 Jan 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Spectranano Laboratories Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 42.36% decrease. The company also saw a substantial improvement in profitability, with a 34.25% increase in profit. The company's net worth observed a substantial decline by a decrease of 43.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Spectranano Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Spectranano Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Spectranano Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectranano Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Spectranano Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Chetan Shankar Sharma was appointed as a Additional Director was appointed as a Additional Director on 07 May 2024 & has been associated with this company since 1 year 7 months . was documented.
Karthik Vithikaa was appointed as a Additional Director was appointed as a Additional Director on 07 May 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.
The activity Spectranano Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
Abhishek Sharma was appointed as a Director was appointed as a Director on 16 Mar 2018 & has been associated with this company since 7 years 9 months . was recorded as a recent event.
The activity Sharada Chaturvedi was appointed as a Director was appointed as a Director on 16 Mar 2018 & has been associated with this company since 7 years 9 months . was completed.
The CIN of Spectranano Laboratories Private Limited is U36999TN2017PTC115401.
Spectranano Laboratories Private Limited is headquartered at Plot No.18A, Old No.27, New No.10, Parameswari Nagar, 2Nd Street, Adyar, Chennai, Tamil Nadu, 600020.
Spectranano Laboratories Private Limited was incorporated on 09 March 2017.
The current directors of Spectranano Laboratories Private Limited are
The primary industry of Spectranano Laboratories Private Limited is Manufacturing.
Spectranano Laboratories Private Limited is unlisted.
The authorized capital of Spectranano Laboratories Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Spectranano Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX